Norovirus

Clinical Microbiology Reviews

Volumn 28, Issue 1, 2015, Pages 134-164

  Robilotti, Elizabeth ^a   Deresinski, Stan ^a   Pinsky, Benjamin A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; VIRUS VACCINE;

ACUTE GASTROENTERITIS; ANIMAL MODEL; ANTIGEN DETECTION; ARMY; ARTICLE; ASYMPTOMATIC INFECTION; CATERING SERVICE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DISINFECTION; ENVIRONMENTAL MONITORING; ENZYME IMMUNOASSAY; FOOD; GRAFT RECIPIENT; HAND WASHING; HEALTH CARE; HEALTH CARE POLICY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOELECTRON MICROSCOPY; IMMUNOLOGY; INCUBATION TIME; INFECTION CONTROL; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MORTALITY; NONHUMAN; NOROVIRUS INFECTION; PATIENT SAFETY; PUBLIC HEALTH SERVICE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL; SHIP; SPORADIC CREUTZFELDT JAKOB DISEASE; VIROLOGY; VIRUS INFECTION; VIRUS SHEDDING; VIRUS TRANSMISSION; CALICIVIRIDAE INFECTIONS; DISEASE NOTIFICATION; GASTROENTERITIS; HOST PATHOGEN INTERACTION; NOROVIRUS; PHYSIOLOGY; STANDARDS;

CALICIVIRIDAE; NOROVIRUS; RNA VIRUSES;

CALICIVIRIDAE INFECTIONS; DISEASE NOTIFICATION; GASTROENTERITIS; HOST-PATHOGEN INTERACTIONS; NOROVIRUS; VIRAL VACCINES;

EID: 84920938944     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00075-14     Document Type: Article

References (394)

1. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM. 1972. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 10:1075-1081.
2. Zahorsky J. 1929. Hyperemesis hiemis or the winter vomiting disease. Arch Pediatr 46:391-395.
3. Adler JL, Zickl R. 1969. Winter vomiting disease. J Infect Dis 119:668-673. http://dx.doi.org/10.1093/infdis/119.6.668.
4. Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM. 1971. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis 123:307-312. http://dx.doi.org/10.1093/infdis/123.3.307.
5. Goodgame R. 2007. Norovirus gastroenteritis. Curr Infect Dis Rep 9:102-109. http://dx.doi.org/10.1007/s11908-007-0004-5.
6. Widdowson M-A, Monroe SS, Glass RI. 2005. Are noroviruses emerging? Emerg Infect Dis 11:735-737. http://dx.doi.org/10.3201/eid1105.041090.
7. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14:1224-1231. http://dx.doi.org/10.3201/eid1408.071114.
8. Kapikian AZ. 2000. The discovery of the 27-nm Norwalk virus: an historic perspective. J Infect Dis 181(Suppl 2):S295-S302.
9. Cukor G, Blacklow NR. 1984. Human viral gastroenteritis. Microbiol Rev 48:157-179.
10. Blacklow NR, Greenberg HB. 1991. Viral gastroenteritis. N Engl J Med 325:252-264. http://dx.doi.org/10.1056/NEJM199107253250406.
11. Greenberg HB, Valdesuso JR, Kalica AR, Wyatt RG, McAuliffe VJ, Kapikian AZ, Chanock RM. 1981. Proteins of Norwalk virus. J Virol 37:994-999.
12. Xi JN, Graham DY, Wang KN, Estes MK. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583. http://dx.doi.org/10.1126/science.2177224.
13. Matsui SM, Kim JP, Greenberg HB, Su W, Sun Q, Johnson PC, DuPont HL, Oshiro LS, Reyes GR. 1991. The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest 87:1456-1461. http://dx.doi.org/10.1172/JCI115152.
14. Jiang X, Wang M, Wang K, Estes MK. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61. http://dx.doi.org/10.1006/viro.1993.1345.
15. Lambden PR, Caul EO, Ashley CR, Clarke IN. 1993. Sequence and genome organization of a human small round-structured (Norwalklike) virus. Science 259:516-519. http://dx.doi.org/10.1126/science.8380940.
16. Green KY. 2013. Caliciviridae: the noroviruses, p 582-608. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
17. Thorne LG, Goodfellow IG. 2014. Norovirus gene expression and replication. J Gen Virol 95:278-291. http://dx.doi.org/10.1099/vir.0.059634-0.
18. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. 2010. Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol 8:231-241. http://dx.doi.org/10.1038/nrmicro2296.
19. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323. http://dx.doi.org/10.1016/j.virol.2005.11.015.
20. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. 2012. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 8:e1002705. http://dx.doi.org/10.1371/journal.ppat.1002705.
21. Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI. 1999. Identification of a distinct common strain of “Norwalk-like viruses” having a global distribution. J Infect Dis 179:1334-1344. http://dx.doi.org/10.1086/314783.
22. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5:e31. http://dx.doi.org/10.1371/journal.pmed.0050031.
23. Widdowson MA, Rockx B, Schepp R, van der Poel WH, Vinje J, van Duynhoven YT, Koopmans MP. 2005. Detection of serum antibodies to bovine norovirus in veterinarians and the general population in theNetherlands. J Med Virol 76:119-128. http://dx.doi.org/10.1002/jmv.20333.
24. Mesquita JR, Costantini VP, Cannon JL, Lin SC, Nascimento MS, Vinje J. 2013. Presence of antibodies against genogroup VI norovirus in humans. Virol J 10:176. http://dx.doi.org/10.1186/1743-422X-10-176.
25. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, Green KY. 2009. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 83:11890-11901. http://dx.doi.org/10.1128/JVI.00864-09.
26. Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 158:2059-2068. http://dx.doi.org/10.1007/s00705-013-1708-5.
27. Bucardo F, Nordgren J, Carlsson B, Kindberg E, Paniagua M, Mollby R, Svensson L. 2010. Asymptomatic norovirus infections in Nicaraguan children and its association with viral properties and histo-blood group antigens. Pediatr Infect Dis J 29:934-939. http://dx.doi.org/10.1097/INF.0b013e3181ed9f2f.
28. Garcia C, DuPont HL, Long KZ, Santos JI, Ko G. 2006. Asymptomatic norovirus infection in Mexican children. J Clin Microbiol 44:2997-3000. http://dx.doi.org/10.1128/JCM.00065-06.
29. Marques Mendanha de Oliveira D, Souza M, Souza Fiaccadori F, Cesar Pereira Santos H, das Dores de Paula Cardoso D. 2014. Monitoring of calicivirus among day-care children: evidence of asymptomatic viral excretion and first report of GI.7 norovirus and GI.3 sapovirus in Brazil. J Med Virol 86:1569-1575. http://dx.doi.org/10.1002/jmv.23791.
30. Huynen P, Mauroy A, Martin C, Savadogo LG, Boreux R, Thiry E, Melin P, De Mol P. 2013. Molecular epidemiology of norovirus infections in symptomatic and asymptomatic children from Bobo Dioulasso, Burkina Faso. J Clin Virol 58:515-521. http://dx.doi.org/10.1016/j.jcv.2013.08.013.
31. Frange P, Touzot F, Debre M, Heritier S, Leruez-Ville M, Cros G, Rouzioux C, Blanche S, Fischer A, Avettand-Fenoel V. 2012. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J Infect Dis 206:1269-1274. http://dx.doi.org/10.1093/infdis/jis498.
32. Phillips G, Tam CC, Rodrigues LC, Lopman B. 2010. Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiol Infect 138:1454-1458. http://dx.doi.org/10.1017/S0950268810000439.
33. Jeong AY, Jeong HS, Lee JS, Park YC, Lee SH, Hwang IG, Kim YJ, Kim YJ, Jo MY, Jung S, Kim K, Cheon DS. 2013. Occurrence of norovirus infections in asymptomatic food handlers in South Korea. J Clin Microbiol 51:598-600. http://dx.doi.org/10.1128/JCM.01856-12.
34. Yu JH, Kim NY, Lee EJ, Jeon IS. 2011. Norovirus infections in asymptomatic food handlers in elementary schools without norovirus outbreaks in some regions of Incheon, Korea. J Korean Med Sci 26:734-739. http://dx.doi.org/10.3346/jkms.2011.26.6.734.
35. Schwartz M, Gluck M, Koon S. 2013. Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am J Gastroenterol 108:1367. http://dx.doi.org/10.1038/ajg.2013.164.
36. Gotz H, Ekdahl K, Lindback J, de Jong B, Hedlund KO, Giesecke J. 2001. Clinical spectrum and transmission characteristics of infection with Norwalk-like virus: findings from a large community outbreak in Sweden. Clin Infect Dis 33:622-628. http://dx.doi.org/10.1086/322608.
37. Lee RM, Lessler J, Lee RA, Rudolph KE, Reich NG, Perl TM, Cummings DA. 2013. Incubation periods of viral gastroenteritis: a systematic review. BMC Infect Dis 13:446. http://dx.doi.org/10.1186/1471-2334-13-446.
38. Rockx B, De Wit M, Vennema H, Vinje J, De Bruin E, Van Duynhoven Y, Koopmans M. 2002. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis 35:246-253. http://dx.doi.org/10.1086/341408.
39. Tseng CY, Chen CH, Su SC, Wu FT, Chen CC, Hsieh GY, Hung CH, Fung CP. 2011. Characteristics of norovirus gastroenteritis outbreaks in a psychiatric centre. Epidemiol Infect 139:275-285. http://dx.doi.org/10.1017/S0950268810000634.
40. Arness MK, Feighner BH, Canham ML, Taylor DN, Monroe SS, Cieslak TJ, Hoedebecke EL, Polyak CS, Cuthie JC, Fankhauser RL, Humphrey CD, Barker TL, Jenkins CD, Skillman DR. 2000. Norwalklike viral gastroenteritis outbreak in U.S. Army trainees. Emerg Infect Dis 6:204-207.
41. Centers for Disease Control and Prevention. 2002. Outbreak of acute gastroenteritis associated with Norwalk-like viruses among British military personnel—Afghanistan, May 2002. MMWR Morb Mortal Wkly Rep 51:477-479.
42. Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DW. 2004. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis 39:318-324. http://dx.doi.org/10.1086/421948.
43. Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, McDonald S, Hall AJ, Parashar UD, Leon JS, Lopman B. 2012. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 55:189-193. http://dx.doi.org/10.1093/cid/cis372.
44. van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, Meijer A, van der Hoek W, Kretzschmar M, Koopmans M. 2012. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis 206:628-639. http://dx.doi.org/10.1093/infdis/jis415.
45. Gustavsson L, Andersson LM, Brink M, Lindh M, Westin J. 2012. Venous lactate levels can be used to identify patients with poor outcome following community-onset norovirus enteritis. Scand J Infect Dis 44: 782-787. http://dx.doi.org/10.3109/00365548.2012.686671.
46. Harris JP, Edmunds WJ, Pebody R, Brown DW, Lopman BA. 2008. Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis 14:1546-1552. http://dx.doi.org/10.3201/eid1410.080188.
47. Murata T, Katsushima N, Mizuta K, Muraki Y, Hongo S, Matsuzaki Y. 2007. Prolonged norovirus shedding in infants _or_6 months of age with gastroenteritis. Pediatr Infect Dis J 26:46-49. http://dx.doi.org/10.1097/01.inf.0000247102.04997.e0.
48. Stuart RL, Tan K, Mahar JE, Kirkwood CD, Andrew Ramsden C, Andrianopoulos N, Jolley D, Bawden K, Doherty R, Kotsanas D, Bradford J, Buttery JP. 2010. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr Infect Dis J 29:644-647. http://dx.doi.org/10.1097/INF.0b013e3181d824e1.
49. Turcios-Ruiz RM, Axelrod P, St John K, Bullitt E, Donahue J, Robinson N, Friss HE. 2008. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J Pediatr 153:339-344. http://dx.doi.org/10.1016/j.jpeds.2008.04.015.
50. Bagci S, Eis-Hubinger AM, Yassin AF, Simon A, Bartmann P, Franz AR, Mueller A. 2010. Clinical characteristics of viral intestinal infection in preterm and term neonates. Eur J Clin Microbiol Infect Dis 29:1079-1084. http://dx.doi.org/10.1007/s10096-010-0965-4.
51. Pelizzo G, Nakib G, Goruppi I, Fusillo M, Scorletti F, Mencherini S, Parigi GB, Stronati M, Calcaterra V. 2013. Isolated colon ischemia with norovirus infection in preterm babies: a case series. J Med Case Rep 7:108. http://dx.doi.org/10.1186/1752-1947-7-108.
52. Zenda T, Kaneko S, Noriki S. 2010. Norovirus gastroenteritis accompanied by ischemic colitis: a case report. Hiroshima J Med Sci 59:83-85.
53. Doshi M, Woodwell S, Kelleher K, Mangan K, Axelrod P. 2013. An outbreak of norovirus infection in a bone marrow transplant unit. Am J Infect Control 41:820-823. http://dx.doi.org/10.1016/j.ajic.2012.10.025.
54. Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M, Flegel WA, Thiel E, Schneider T. 2011. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 117:5850-5856. http://dx.doi.org/10.1182/blood-2010-12-325886.
55. Roddie C, Paul JP, Benjamin R, Gallimore CI, Xerry J, Gray JJ, Peggs KS, Morris EC, Thomson KJ, Ward KN. 2009. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis 49:1061-1068. http://dx.doi.org/10.1086/605557.
56. Robles JD, Cheuk DK, Ha SY, Chiang AK, Chan GC. 2012. Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 18: 1883-1889. http://dx.doi.org/10.1016/j.bbmt.2012.07.005.
57. Saif MA, Bonney DK, Bigger B, Forsythe L, Williams N, Page J, Babiker ZO, Guiver M, Turner AJ, Hughes S, Wynn RF. 2011. Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support. Pediatr Transplant 15:505-509. http://dx.doi.org/10.1111/j.1399-3046.2011.01500.x.
58. Florescu DF, Hermsen ED, Kwon JY, Gumeel D, Grant WJ, Mercer DF, Kalil AC. 2011. Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant 15:718-721. http://dx.doi.org/10.1111/j.1399-3046.2011.01556.x.
59. Westhoff TH, Vergoulidou M, Loddenkemper C, Schwartz S, Hofmann J, Schneider T, Zidek W, van der Giet M. 2009. Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant 24:1051-1053. http://dx.doi.org/10.1093/ndt/gfn693.
60. Schorn R, Hohne M, Meerbach A, Bossart W, Wuthrich RP, Schreier E, Muller NJ, Fehr T. 2010. Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. Clin Infect Dis 51:307-314. http://dx.doi.org/10.1086/653939.
61. Roos-Weil D, Ambert-Balay K, Lanternier F, Mamzer-Bruneel MF, Nochy D, Pothier P, Avettand-Fenoel V, Anglicheau D, Snanoudj R, Bererhi L, Thervet E, Lecuit M, Legendre C, Lortholary O, Zuber J. 2011. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 92:61-69. http://dx.doi.org/10.1097/TP.0b013e31821c9392.
62. Coste JF, Vuiblet V, Moustapha B, Bouin A, Lavaud S, Toupance O, de Rougemont A, Benejat L, Megraud F, Wolak-Thierry A, Villena I, Chemla C, Le Magrex E, de Champs C, Andreoletti L, Rieu P, Leveque N. 2013. Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays. J Clin Microbiol 51: 1841-1849. http://dx.doi.org/10.1128/JCM.03366-12.
63. Capizzi T, Makari-Judson G, Steingart R, Mertens WC. 2011. Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases. BMC Infect Dis 11: 131. http://dx.doi.org/10.1186/1471-2334-11-131.
64. Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, Guiver M, Blanchard TJ. 2010. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J Clin Virol 49:219-222. http://dx.doi.org/10.1016/j.jcv.2010.07.025.
65. Esposito S, Daleno C, Scala A, Senatore L, Ascolese B, Principi N. 2014. Detection of norovirus in respiratory secretions in children with respiratory tract infection. Pediatr Infect Dis J 33:314-316. http://dx.doi.org/10.1097/INF.0000000000000035.
66. Armbrust S, Kramer A, Olbertz D, Zimmermann K, Fusch C. 2009. Norovirus infections in preterm infants: wide variety of clinical courses. BMC Res Notes 2:96. http://dx.doi.org/10.1186/1756-0500-2-96.
67. Salvador C, Meister B, Larcher H, Crazzolara R, Kropshofer G. 2014. Hemophagocytic lymphohistiocytosis after allogeneic bone marrow transplantation during chronic norovirus infection. Hematol Oncol 32: 102-106. http://dx.doi.org/10.1002/hon.2052.
68. Chehade H, Girardin E, Delich V, Pascual MA, Venetz JP, Cachat F. 2012. Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient. Transpl Infect Dis 14:E27-E29. http://dx.doi.org/10.1111/j.1399-3062.2012.00754.x.
69. Sugimoto T, Ogawa N, Aoyama M, Sakaguchi M, Isshiki K, Kanasaki M, Uzu T, Nishio Y, Eguchi Y, Kashiwagi A. 2007. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant 22:2098-2099. http://dx.doi.org/10.1093/ndt/gfm104.
70. Zenda T, Miyamoto M, Kaneko S. 2011. Norovirus gastroenteritis accompanied by marked elevation of transaminases. Hiroshima J Med Sci 60:41-43.
71. Tsuge M, Goto S, Kato F, Morishima T. 2010. Elevation of serum transaminases with norovirus infection. Clin Pediatr (Phila) 49:574-578. http://dx.doi.org/10.1177/0009922809353593.
72. Gemulla G, Pessler F. 2011. Can norovirus infection lead to a postinfectious arthritis? Report of 2 possible cases. Klin Padiatr 223:43-44. http://dx.doi.org/10.1055/s-0030-1263143.
73. Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A, San Felice del Benaco Study Investigators. 2012. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol 107:891-899. http://dx.doi.org/10.1038/ajg.2012.102.
74. Khan RR, Lawson AD, Minnich LL, Martin K, Nasir A, Emmett MK, Welch CA, Udall JN, Jr. 2009. Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 48:328-333. http://dx.doi.org/10.1097/MPG.0b013e31818255cc.
75. Kolho KL, Klemola P, Simonen-Tikka ML, Ollonen ML, Roivainen M. 2012. Enteric viral pathogens in children with inflammatory bowel disease. J Med Virol 84:345-347. http://dx.doi.org/10.1002/jmv.23193.
76. Masclee GM, Penders J, Pierik M, Wolffs P, Jonkers D. 2013. Enteropathogenic viruses: triggers for exacerbation in IBD? A prospective cohort study using real-time quantitative polymerase chain reaction. Inflamm Bowel Dis 19:124-131. http://dx.doi.org/10.1002/ibd.22976.
77. Porter CK, Faix DJ, Shiau D, Espiritu J, Espinosa BJ, Riddle MS. 2012. Postinfectious gastrointestinal disorders following norovirus outbreaks. Clin Infect Dis 55:915-922. http://dx.doi.org/10.1093/cid/cis576.
78. Ito S, Takeshita S, Nezu A, Aihara Y, Usuku S, Noguchi Y, Yokota S. 2006. Norovirus-associated encephalopathy. Pediatr Infect Dis J 25:651-652. http://dx.doi.org/10.1097/01.inf.0000225789.92512.6d.
79. Kimura E, Goto H, Migita A, Harada S, Yamashita S, Hirano T, Uchino M. 2010. An adult norovirus-related encephalitis/encephalopathy with mild clinical manifestation. BMJ Case Rep 2010:bcr0320102784. http://dx.doi.org/10.1136/bcr.03.2010.2784.
80. Obinata K, Okumura A, Nakazawa T, Kamata A, Niizuma T, Kinoshita K, Shimizu T. 2010. Norovirus encephalopathy in a previously healthy child. Pediatr Infect Dis J 29:1057-1059. http://dx.doi.org/10.1097/INF.0b013e3181e78889.
81. Medici MC, Abelli LA, Dodi I, Dettori G, Chezzi C. 2010. Norovirus RNA in the blood of a child with gastroenteritis and convulsions—a case report. J Clin Virol 48:147-149. http://dx.doi.org/10.1016/j.jcv.2010.03.001.
82. Takanashi S, Hashira S, Matsunaga T, Yoshida A, Shiota T, Tung PG, Khamrin P, Okitsu S, Mizuguchi M, Igarashi T, Ushijima H. 2009. Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J Clin Virol 44:161-163. http://dx.doi.org/10.1016/j.jcv.2008.11.011.
83. Chan CM, Chan CW, Ma CK, Chan HB. 2011. Norovirus as cause of benign convulsion associated with gastro-enteritis. J Paediatr Child Health 47:373-377. http://dx.doi.org/10.1111/j.1440-1754.2010.01986.x.
84. Chen SY, Tsai CN, Lai MW, Chen CY, Lin KL, Lin TY, Chiu CH. 2009. Norovirus infection as a cause of diarrhea-associated benign infantile seizures. Clin Infect Dis 48:849-855. http://dx.doi.org/10.1086/597256.
85. Rossignol JF, El-Gohary YM. 2006. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment Pharmacol Ther 24:1423-1430. http://dx.doi.org/10.1111/j.1365-2036.2006.03128.x.
86. Siddiq DM, Koo HL, Adachi JA, Viola GM. 2011. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect 63:394-397. http://dx.doi.org/10.1016/j.jinf.2011.08.002.
87. Chagla Z, Quirt J, Woodward K, Neary J, Rutherford C. 2013. Chronic norovirus infection in a transplant patient successfully treated with enterally administered immune globulin. J Clin Virol 58:306-308. http://dx.doi.org/10.1016/j.jcv.2013.06.009.
88. Chen Z, Sosnovtsev SV, Bok K, Parra GI, Makiya M, Agulto L, Green KY, Purcell RH. 2013. Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol 87:9547-9557. http://dx.doi.org/10.1128/JVI.01376-13.
89. Boillat Blanco N, Kuonen R, Bellini C, Manuel O, Estrade C, Mazza-Stalder J, Aubert JD, Sahli R, Meylan P. 2011. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis 13:213-215. http://dx.doi.org/10.1111/j.1399-3062.2010.00565.x.
90. Engelen MA, Gunia S, Stypmann J. 2011. Elimination of norovirus in a chronic carrier under immunosuppression after heart transplantation—effect of everolimus. Transpl Int 24:e102-e103. http://dx.doi.org/10.1111/j.1432-2277.2011.01330.x.
91. Ochoa TJ, Chea-Woo E, Baiocchi N, Pecho I, Campos M, Prada A, Valdiviezo G, Lluque A, Lai D, Cleary TG. 2013. Randomized doubleblind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr 162:349-356. http://dx.doi.org/10.1016/j.jpeds.2012.07.043.
92. Nagata S, Asahara T, Ohta T, Yamada T, Kondo S, Bian L, Wang C, Yamashiro Y, Nomoto K. 2011. Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br J Nutr 106:549-556. http://dx.doi.org/10.1017/S000711451100064X.
93. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N Engl J Med 361:1776-1785. http://dx.doi.org/10.1056/NEJMra0804575.
94. Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT, Wikswo M, Shirley SH, Hall AJ, Lopman B, Parashar UD. 2013. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 368:1121-1130. http://dx.doi.org/10.1056/NEJMsa1206589.
95. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O’Brien SJ, IID2 Study Executive Committee. 2012. Longitudinal study of infectious intestinal disease in theUK(IID2 study): incidence in the community and presenting to general practice. Gut 61:69-77. http://dx.doi.org/10.1136/gut.2011.238386.
96. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O’Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
97. Chikhi-Brachet R, Bon F, Toubiana L, Pothier P, Nicolas JC, Flahault A, Kohli E. 2002. Virus diversity in a winter epidemic of acute diarrhea in France. J Clin Microbiol 40:4266-4272. http://dx.doi.org/10.1128/JCM.40.11.4266-4272.2002.
98. Patel MM, Hall AJ, Vinje J, Parashar UD. 2009. Noroviruses: a comprehensive review. J Clin Virol 44:1-8. http://dx.doi.org/10.1016/j.jcv.2008.10.009.
99. Rha B, Burrer S, Park S, Trivedi T, Parashar UD, Lopman BA. 2013. Emergency department visit data for rapid detection and monitoring of norovirus activity, United States. Emerg Infect Dis 19:1214-1221. http://dx.doi.org/10.3201/eid1908.130483.
100. Kirking HL, Cortes J, Burrer S, Hall AJ, Cohen NJ, Lipman H, Kim C, Daly ER, Fishbein DB. 2010. Likely transmission of norovirus on an airplane, October 2008. Clin Infect Dis 50:1216-1221. http://dx.doi.org/10.1086/651597.
101. Wikswo ME, Cortes J, Hall AJ, Vaughan G, Howard C, Gregoricus N, Cramer EH. 2011. Disease transmission and passenger behaviors during a high morbidity Norovirus outbreak on a cruise ship, January 2009. Clin Infect Dis 52:1116-1122. http://dx.doi.org/10.1093/cid/cir144.
102. Matthews JE, Dickey BW, Miller RD, Felzer JR, Dawson BP, Lee AS, Rocks JJ, Kiel J, Montes JS, Moe CL, Eisenberg JN, Leon JS. 2012. The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup. Epidemiol Infect 140:1161-1172. http://dx.doi.org/10.1017/S0950268812000234.
103. Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinje J. 2014. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol 52:147-155. http://dx.doi.org/10.1128/JCM.02680-13.
104. Lopman B, Gastanaduy P, Park GW, Hall AJ, Parashar UD, Vinje J. 2012. Environmental transmission of norovirus gastroenteritis. Curr Opin Virol 2:96-102. http://dx.doi.org/10.1016/j.coviro.2011.11.005.
105. Heijne JC, Teunis P, Morroy G, Wijkmans C, Oostveen S, Duizer E, Kretzschmar M, Wallinga J. 2009. Enhanced hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis 15:24-30. http://dx.doi.org/10.3201/eid1501.080299.
106. Kaplan JE, Goodman RA, Schonberger LB, Lippy EC, Gary GW. 1982. Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J Infect Dis 146:190-197. http://dx.doi.org/10.1093/infdis/146.2.190.
107. Cannon RO, Poliner JR, Hirschhorn RB, Rodeheaver DC, Silverman PR, Brown EA, Talbot GH, Stine SE, Monroe SS, Dennis DT, Glass RI. 1991. A multistate outbreak of Norwalk virus gastroenteritis associated with consumption of commercial ice. J Infect Dis 164:860-863. http://dx.doi.org/10.1093/infdis/164.5.860.
108. Wilson R, Anderson LJ, Holman RC, Gary GW, Greenberg HB. 1982. Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation. Am J Public Health 72:72-74. http://dx.doi.org/10.2105/AJPH.72.1.72.
109. ter Waarbeek HL, Dukers-Muijrers NH, Vennema H, Hoebe CJ. 2010. Waterborne gastroenteritis outbreak at a scouting camp caused by two norovirus genogroups: GI and GII. J Clin Virol 47:268-272. http://dx.doi.org/10.1016/j.jcv.2009.12.002.
110. Jones EL, Gaither M, Kramer A, Gerba CP. 2009. An analysis of water quality in the Colorado River, 2003-04; an investigation into recurring outbreaks of norovirus among rafters. Wilderness Environ Med 20:6-13. http://dx.doi.org/10.1580/06-WEME-OR-43.1.
111. Koopman JS, Eckert EA, Greenberg HB, Strohm BC, Isaacson RE, Monto AS. 1982. Norwalk virus enteric illness acquired by swimming exposure. Am J Epidemiol 115:173-177.
112. Koh SJ, Cho HG, Kim BH, Choi BY. 2011. An outbreak of gastroenteritis caused by norovirus-contaminated groundwater at a waterpark in Korea. J Korean Med Sci 26:28-32. http://dx.doi.org/10.3346/jkms.2011.26.1.28.
113. Gentry J, Vinje J, Guadagnoli D, Lipp EK. 2009. Norovirus distribution within an estuarine environment. Appl Environ Microbiol 75:5474-5480. http://dx.doi.org/10.1128/AEM.00111-09.
114. Victoria M, Guimaraes FR, Fumian TM, Ferreira FF, Vieira CB, Shubo T, Leite JP, Miagostovich MP. 2010. One year monitoring of norovirus in a sewage treatment plant in Rio de Janeiro, Brazil. J Water Health 8:158-165. http://dx.doi.org/10.2166/wh.2009.012.
115. da Silva AK, Le Guyader FS, Le Saux JC, Pommepuy M, Montgomery MA, Elimelech M. 2008. Norovirus removal and particle association in a waste stabilization pond. Environ Sci Technol 42:9151-9157. http://dx.doi.org/10.1021/es802787v.
116. da Silva AK, Le Saux JC, Parnaudeau S, Pommepuy M, Elimelech M, Le Guyader FS. 2007. Evaluation of removal of noroviruses during wastewater treatment, using real-time reverse transcription-PCR: different behaviors of genogroups I and II. Appl Environ Microbiol 73:7891-7897. http://dx.doi.org/10.1128/AEM.01428-07.
117. Sima LC, Schaeffer J, Le Saux JC, Parnaudeau S, Elimelech M, Le Guyader FS. 2011. Calicivirus removal in a membrane bioreactor wastewater treatment plant. Appl Environ Microbiol 77:5170-5177. http://dx.doi.org/10.1128/AEM.00583-11.
118. Kukkula M, Maunula L, Silvennoinen E, von Bonsdorff CH. 1999. Outbreak of viral gastroenteritis due to drinking water contaminated by Norwalk-like viruses. J Infect Dis 180:1771-1776. http://dx.doi.org/10.1086/315145.
119. Alfano-Sobsey E, Sweat D, Hall A, Breedlove F, Rodriguez R, Greene S, Pierce A, Sobsey M, Davies M, Ledford SL. 2012. Norovirus outbreak associated with undercooked oysters and secondary household transmission. Epidemiol Infect 140:276-282. http://dx.doi.org/10.1017/S0950268811000665.
120. Lowther JA, Gustar NE, Powell AL, Hartnell RE, Lees DN. 2012. Two-year systematic study to assess norovirus contamination in oysters from commercial harvesting areas in the United Kingdom. Appl Environ Microbiol 78:5812-5817. http://dx.doi.org/10.1128/AEM.01046-12.
121. Lowther JA, Henshilwood K, Lees DN. 2008. Determination of norovirus contamination in oysters from two commercial harvesting areas over an extended period, using semiquantitative real-time reverse transcription PCR. J Food Prot 71:1427-1433.
122. McLeod C, Hay B, Grant C, Greening G, Day D. 2009. Localization of norovirus and poliovirus in Pacific oysters. J Appl Microbiol 106:1220-1230. http://dx.doi.org/10.1111/j.1365-2672.2008.04091.x.
123. Kim HY, Kwak IS, Hwang IG, Ko G. 2008. Optimization of methods for detecting norovirus on various fruit. J Virol Methods 153:104-110. http://dx.doi.org/10.1016/j.jviromet.2008.07.022.
124. Tian P, Yang D, Mandrell R. 2011. Differences in the binding of human norovirus to and from romaine lettuce and raspberries by water and electrolyzed waters. J Food Prot 74:1364-1369. http://dx.doi.org/10.4315/0362-028X.JFP-10-494.
125. Tian P, Yang D, Mandrell R. 2011. A simple method to recover norovirus from fresh produce with large sample size by using histo-blood group antigen-conjugated to magnetic beads in a recirculating affinity magnetic separation system (RCAMS). Int J Food Microbiol 147:223-227. http://dx.doi.org/10.1016/j.ijfoodmicro.2011.04.013.
126. Brugha R, Vipond IB, Evans MR, Sandifer QD, Roberts RJ, Salmon RL, Caul EO, Mukerjee AK. 1999. A community outbreak of food-borne small round-structured virus gastroenteritis caused by a contaminated water supply. Epidemiol Infect 122:145-154. http://dx.doi.org/10.1017/S0950268898001885.
127. Dore B, Keaveney S, Flannery J, Rajko-Nenow P. 2010. Management of health risks associated with oysters harvested from a norovirus contaminated area, Ireland, February-March 2010. Euro Surveill 15(19): pii_19567. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19567.
128. Malik YS, Goyal SM. 2006. Virucidal efficacy of sodium bicarbonate on a food contact surface against feline calicivirus, a norovirus surrogate. Int J Food Microbiol 109:160-163. http://dx.doi.org/10.1016/j.ijfoodmicro.2005.08.033.
129. Kim SW, Baek SB, Ha JH, Lee MH, Choi C, Ha SD. 2012. Chlorine treatment to inactivate norovirus on food contact surfaces. J Food Prot 75:184-188. http://dx.doi.org/10.4315/0362-028X.JFP-11-243.
130. Kuo HW, Schmid D, Jelovcan S, Pichler AM, Magnet E, Reichart S, Allerberger F. 2009. A foodborne outbreak due to norovirus in Austria, 2007. J Food Prot 72:193-196.
131. Anderson AD, Garrett VD, Sobel J, Monroe SS, Fankhauser RL, Schwab KJ, Bresee JS, Mead PS, Higgins C, Campana J, Glass RI, Outbreak Investigation Team. 2001. Multistate outbreak of Norwalklike virus gastroenteritis associated with a common caterer. Am J Epidemiol 154:1013-1019. http://dx.doi.org/10.1093/aje/154.11.1013.
132. Fallahi S, Mattison K. 2011. Evaluation of murine norovirus persistence in environments relevant to food production and processing. J Food Prot 74:1847-1851. http://dx.doi.org/10.4315/0362-028X.JFP-11-081.
133. Pang XL, Preiksaitis JK, Lee BE. 2014. Enhanced enteric virus detection in sporadic gastroenteritis using a multi-target real-time PCR panel: a one-year study. J Med Virol 86:1594-1601. http://dx.doi.org/10.1002/jmv.23851.
134. Monica B, Ramani S, Banerjee I, Primrose B, Iturriza-Gomara M, Gallimore CI, Brown DW, Fathima M, Moses PD, Gray JJ, Kang G. 2007. Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India. J Med Virol 79:544-551. http://dx.doi.org/10.1002/jmv.20862.
135. Bon F, Fascia P, Dauvergne M, Tenenbaum D, Planson H, Petion AM, Pothier P, Kohli E. 1999. Prevalence of group A rotavirus, human calicivirus, astrovirus, and adenovirus type 40 and 41 infections among children with acute gastroenteritis in Dijon, France. J Clin Microbiol 37: 3055-3058.
136. O’Ryan ML, Mamani N, Gaggero A, Avendano LF, Prieto S, Pena A, Jiang X, Matson DO. 2000. Human caliciviruses are a significant pathogen of acute sporadic diarrhea in children of Santiago, Chile. J Infect Dis 182:1519-1522. http://dx.doi.org/10.1086/315874.
137. Dove W, Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux ME, Nakagomi O, Hart CA. 2005. Detection and characterization of human caliciviruses in hospitalized children with acute gastroenteritis in Blantyre, Malawi. J Med Virol 77:522-527. http://dx.doi.org/10.1002/jmv.20488.
138. Malasao R, Maneekarn N, Khamrin P, Pantip C, Tonusin S, Ushijima H, Peerakome S. 2008. Genetic diversity of norovirus, sapovirus, and astrovirus isolated from children hospitalized with acute gastroenteritis in Chiang Mai, Thailand. J Med Virol 80:1749-1755. http://dx.doi.org/10.1002/jmv.21244.
139. Pang XL, Joensuu J, Vesikari T. 1999. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J 18:420-426. http://dx.doi.org/10.1097/00006454-199905000-00005.
140. O’Ryan ML, Lucero Y, Prado V, Santolaya ME, Rabello M, Solis Y, Berrios D, O’Ryan-Soriano MA, Cortes H, Mamani N. 2009. Symptomatic and asymptomatic rotavirus and norovirus infections during infancy in a Chilean birth cohort. Pediatr Infect Dis J 28:879-884. http://dx.doi.org/10.1097/INF.0b013e3181a4bb60.
141. Kirkwood CD, Clark R, Bogdanovic-Sakran N, Bishop RF. 2005. A 5-year study of the prevalence and genetic diversity of human caliciviruses associated with sporadic cases of acute gastroenteritis in young children admitted to hospital in Melbourne, Australia (1998-2002). J Med Virol 77:96-101. http://dx.doi.org/10.1002/jmv.20419.
142. Zintz C, Bok K, Parada E, Barnes-Eley M, Berke T, Staat MA, Azimi P, Jiang X, Matson DO. 2005. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect Genet Evol 5:281-290. http://dx.doi.org/10.1016/j.meegid.2004.06.010.
143. Zingg W, Colombo C, Jucker T, Bossart W, Ruef C. 2005. Impact of an outbreak of norovirus infection on hospital resources. Infect Control Hosp Epidemiol 26:263-267. http://dx.doi.org/10.1086/502537.
144. Mattner F, Mattner L, Borck HU, Gastmeier P. 2005. Evaluation of the impact of the source (patient versus staff) on nosocomial norovirus outbreak severity. Infect Control Hosp Epidemiol 26:268-272. http://dx.doi.org/10.1086/502538.
145. Pether JV, Caul EO. 1983. An outbreak of food-borne gastroenteritis in two hospitals associated with a Norwalk-like virus. J Hyg (Lond) 91:343-350. http://dx.doi.org/10.1017/S0022172400060368.
146. Centers for Disease Control and Prevention. 2008. Norovirus outbreak in an elementary school—District of Columbia, February 2007.MMWR Morb Mortal Wkly Rep 56:1340-1343.
147. Centers for Disease Control and Prevention. 2009. Norovirus outbreaks on three college campuses—California, Michigan, and Wisconsin, 2008. MMWR Morb Mortal Wkly Rep 58:1095-1100.
148. Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO. 2003. A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect 131:727-736. http://dx.doi.org/10.1017/S0950268803008689.
149. McCarthy M, Estes MK, Hyams KC. 2000. Norwalk-like virus infection in military forces: epidemic potential, sporadic disease, and the future direction of prevention and control efforts. J Infect Dis 181(Suppl 2): S387-S391. http://dx.doi.org/10.1086/315582.
150. Mayet A, Andreo V, Bedubourg G, Victorion S, Plantec J, Soullie B, Meynard J, Dedieu J, Polveche P, Migliani R. 2011. Food-borne outbreak of norovirus infection in a French military parachuting unit, April 2011. Euro Surveill 16(30):pii_19930. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19930.
151. Chapman AS, Witkop CT, Escobar JD, Schlorman CA, DeMarcus LS, Marmer LM, Crum ME. 2011. Norovirus outbreak associated with person-to-person transmission, US Air Force Academy, July 2011. MSMR 18(11):2-5.
152. Gunn RA, Terranova WA, Greenberg HB, Yashuk J, Gary GW, Wells JG, Taylor PR, Feldman RA. 1980. Norwalk virus gastroenteritis aboard a cruise ship: an outbreak on five consecutive cruises. Am J Epidemiol 112:820-827.
153. Addiss DG, Yashuk JC, Clapp DE, Blake PA. 1989. Outbreaks of diarrhoeal illness on passenger cruise ships, 1975-85. Epidemiol Infect 103:63-72. http://dx.doi.org/10.1017/S0950268800030363.
154. Centers for Disease Control and Prevention. 2002. Outbreaks of gastroenteritis associated with noroviruses on cruise ships—United States, 2002. MMWR Morb Mortal Wkly Rep 51:1112-1115.
155. Widdowson MA, Cramer EH, Hadley L, Bresee JS, Beard RS, Bulens SN, Charles M, Chege W, Isakbaeva E, Wright JG, Mintz E, Forney D, Massey J, Glass RI, Monroe SS. 2004. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus—United States, 2002. J Infect Dis 190:27-36. http://dx.doi.org/10.1086/420888.
156. Centers for Disease Control and Prevention. 4 April 2014, posting date. Outbreak updates for international cruise ships. Vessel sanitation program. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/nceh/vsp/surv/gilist.htm.
157. Domenech-Sanchez A. 2011. Gastroenteritis outbreak caused by norovirus associated with the children’s club of a hotel located in Majorca, Spain. Clin Microbiol Infect 17:949-951. http://dx.doi.org/10.1111/j.1469-0691.2010.03342.x.
158. Domenech-Sanchez A, Juan C, Perez JL, Berrocal CI. 2011. Unmanageable norovirus outbreak in a single resort located in the Dominican Republic. Clin Microbiol Infect 17:952-954. http://dx.doi.org/10.1111/j.1469-0691.2010.03411.x.
159. Hauri AM, Westbrock HJ, Claus H, Geis S, Giernat S, Forssbohm M, Uphoff H. 2011. Electronic outbreak surveillance in Germany: a first evaluation for nosocomial norovirus outbreaks. PLoS One 6:e17341. http://dx.doi.org/10.1371/journal.pone.0017341.
160. van Beek J, Ambert-Balay K, Botteldoorn N, Eden JS, Fonager J, Hewitt J, Iritani N, Kroneman A, Vennema H, Vinje J, White PA, Koopmans M. 2013. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill 18(1):pii_20345. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20345.
161. Koopmans M, Vennema H, Heersma H, van Strien E, van Duynhoven Y, Brown D, Reacher M, Lopman B, European Consortium on Foodborne Viruses. 2003. Early identification of common-source foodborne virus outbreaks in Europe. Emerg Infect Dis 9:1136-1142. http://dx.doi.org/10.3201/eid0909.020766.
162. Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV, CDC PulseNet Task Force. 2001. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 7:382-389. http://dx.doi.org/10.3201/eid0703.017303.
163. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinje J. 2011. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 17:1389-1395. http://dx.doi.org/10.3201/eid1708.101837.
164. Centers for Disease Control and Prevention. 2013. Emergence of new norovirus strain GII.4 Sydney—United States, 2012. MMWR Morb Mortal Wkly Rep 62:55.
165. Harris JP, Adams NL, Lopman BA, Allen DJ, Adak GK. 2014. The development of Web-based surveillance provides new insights into the burden of norovirus outbreaks in hospitals in England. Epidemiol Infect 142:1590-1598. http://dx.doi.org/10.1017/S0950268813002896.
166. Scallan E. 2007. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996-2005. Clin Infect Dis 44:718-725. http://dx.doi.org/10.1086/511648.
167. Kirk MD, McKay I, Hall GV, Dalton CB, Stafford R, Unicomb L, Gregory J. 2008. Food safety: foodborne disease in Australia. The OzFoodNet experience. Clin Infect Dis 47:392-400. http://dx.doi.org/10.1086/589861.
168. Kaplan JE, Feldman R, Campbell DS, Lookabaugh C, Gary GW. 1982. The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health 72:1329-1332. http://dx.doi.org/10.2105/AJPH.72.12.1329.
169. Turcios RM, Widdowson MA, Sulka AC, Mead PS, Glass RI. 2006. Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000. Clin Infect Dis 42:964-969. http://dx.doi.org/10.1086/500940.
170. Centers for Disease Control and Prevention. 12 April 2012, posting date. Norovirus specimen collection. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/norovirus/lab-testing/collection.html.
171. Costantini V, Grenz L, Fritzinger A, Lewis D, Biggs C, Hale A, Vinje J. 2010. Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus. J Clin Microbiol 48:2770-2778. http://dx.doi.org/10.1128/JCM.00654-10.
172. Gray JJ, Kohli E, Ruggeri FM, Vennema H, Sanchez-Fauquier A, Schreier E, Gallimore CI, Iturriza-Gomara M, Giraudon H, Pothier P, Di Bartolo I, Inglese N, de Bruin E, van der Veer B, Moreno S, Montero V, de Llano MC, Hohne M, Diedrich SM. 2007. European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin Vaccine Immunol 14:1349-1355. http://dx.doi.org/10.1128/CVI.00214-07.
173. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. 2004. Laboratory efforts to cultivate noroviruses. J Gen Virol 85:79-87. http://dx.doi.org/10.1099/vir.0.19478-0.
174. Centers for Disease Control and Prevention. 2011. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recommend Rep 60(RR3):1-18.
175. De Leon R, Matsui SM, Baric RS, Herrmann JE, Blacklow NR, Greenberg HB, Sobsey MD. 1992. Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol 30:3151-3157.
176. Green J, Norcott JP, Lewis D, Arnold C, Brown DW. 1993. Norwalklike viruses: demonstration of genomic diversity by polymerase chain reaction. J Clin Microbiol 31:3007-3012.
177. Jiang X, Wang J, Graham DY, Estes MK. 1992. Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol 30:2529-2534.
178. Moe CL, Gentsch J, Ando T, Grohmann G, Monroe SS, Jiang X, Wang J, Estes MK, Seto Y, Humphrey C, Stine S, Glass RI. 1994. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol 32:642-648.
179. Ando T, Monroe SS, Gentsch JR, Jin Q, Lewis DC, Glass RI. 1995. Detection and differentiation of antigenically distinct small roundstructured viruses (Norwalk-like viruses) by reverse transcription-PCR and Southern hybridization. J Clin Microbiol 33:64-71.
180. Green J, Gallimore CI, Norcott JP, Lewis D, Brown DW. 1995. Broadly reactive reverse transcriptase polymerase chain reaction for the diagnosis of SRSV-associated gastroenteritis. J Med Virol 47:392-398. http://dx.doi.org/10.1002/jmv.1890470416.
181. Le Guyader F, Estes MK, Hardy ME, Neill FH, Green J, Brown DW, Atmar RL. 1996. Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch Virol 141:2225-2235. http://dx.doi.org/10.1007/BF01718228.
182. Vinje J, Koopmans MP. 1996. Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. J Infect Dis 174:610-615. http://dx.doi.org/10.1093/infdis/174.3.610.
183. Vinje J, Vennema H, Maunula L, von Bonsdorff CH, Hoehne M, Schreier E, Richards A, Green J, Brown D, Beard SS, Monroe SS, de Bruin E, Svensson L, Koopmans MP. 2003. International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J Clin Microbiol 41:1423-1433. http://dx.doi.org/10.1128/JCM.41.4.1423-1433.2003.
184. Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M, Uchida K, Natori K, Takeda N, Katayama K. 2002. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods 100:107-114. http://dx.doi.org/10.1016/S0166-0934(01)00404-9.
185. Medici MC, Martinelli M, Ruggeri FM, Abelli LA, Bosco S, Arcangeletti MC, Pinardi F, De Conto F, Calderaro A, Chezzi C, Dettori G. 2005. Broadly reactive nested reverse transcription-PCR using an internal RNA standard control for detection of noroviruses in stool samples. J Clin Microbiol 43:3772-3778. http://dx.doi.org/10.1128/JCM.43.8.3772-3778.2005.
186. O’Neill HJ, McCaughey C, Wyatt DE, Mitchell F, Coyle PV. 2001. Gastroenteritis outbreaks associated with Norwalk-like viruses and their investigation by nested RT-PCR. BMC Microbiol 1:14. http://dx.doi.org/10.1186/1471-2180-1-14.
187. Saito H, Saito S, Kamada K, Harata S, Sato H, Morita M, Miyajima Y. 1998. Application of RT-PCR designed from the sequence of the local SRSV strain to the screening in viral gastroenteritis outbreaks. Microbiol Immunol 42:439-446. http://dx.doi.org/10.1111/j.1348-0421.1998.tb02307.x.
188. Schreier E, Doring F, Kunkel U. 2000. Molecular epidemiology of outbreaks of gastroenteritis associated with small round structured viruses in Germany in 1997/98. Arch Virol 145:443-453. http://dx.doi.org/10.1007/s007050050038.
189. Vennema H, de Bruin E, Koopmans M. 2002. Rational optimization of generic primers used for Norwalk-like virus detection by reverse transcriptase polymerase chain reaction. J Clin Virol 25:233-235. http://dx.doi.org/10.1016/S1386-6532(02)00126-9.
190. Miller I, Gunson R, Carman WF. 2002. Norwalk like virus by light cycler PCR. J Clin Virol 25:231-232. http://dx.doi.org/10.1016/S1386-6532(02)00110-5.
191. Pang X, Lee B, Chui L, Preiksaitis JK, Monroe SS. 2004. Evaluation and validation of real-time reverse transcription-PCR assay using the LightCycler system for detection and quantitation of norovirus. J Clin Microbiol 42:4679-4685. http://dx.doi.org/10.1128/JCM.42.10.4679-4685.2004.
192. Richards GP, Watson MA, Kingsley DH. 2004. A SYBR green, real-time RT-PCR method to detect and quantitate Norwalk virus in stools. J Virol Methods 116:63-70. http://dx.doi.org/10.1016/j.jviromet.2003.10.011.
193. Schmid M, Oehme R, Schalasta G, Brockmann S, Kimmig P, Enders G. 2004. Fast detection of noroviruses using a real-time PCR assay and automated sample preparation. BMC Infect Dis 4:15. http://dx.doi.org/10.1186/1471-2334-4-15.
194. Dreier J, Stormer M, Made D, Burkhardt S, Kleesiek K. 2006. Enhanced reverse transcription-PCR assay for detection of norovirus genogroup I. J Clin Microbiol 44:2714-2720. http://dx.doi.org/10.1128/JCM.00443-06.
195. Hoehne M, Schreier E. 2006. Detection of norovirus genogroup I and II by multiplex real-time RT-PCR using a 3=-minor groove binder-DNA probe. BMC Infect Dis 6:69. http://dx.doi.org/10.1186/1471-2334-6-69.
196. Hohne M, Schreier E. 2004. Detection and characterization of norovirus outbreaks in Germany: application of a one-tube RT-PCR using a fluorogenic real-time detection system. J Med Virol 72:312-319. http://dx.doi.org/10.1002/jmv.10573.
197. Ishida S, Yoshizumi S, Ikeda T, Miyoshi M, Okano M, Okui T. 2008. Sensitive and rapid detection of norovirus using duplex TaqMan reverse transcription-polymerase chain reaction. J Med Virol 80:913-920. http://dx.doi.org/10.1002/jmv.21142.
198. Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Takeda N, Katayama K. 2003. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 41:1548-1557. http://dx.doi.org/10.1128/JCM.41.4.1548-1557.2003.
199. Logan C, O’Leary JJ, O’Sullivan N. 2007. Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis. J Virol Methods 146:36-44. http://dx.doi.org/10.1016/j.jviromet.2007.05.031.
200. Rolfe KJ, Parmar S, Mururi D, Wreghitt TG, Jalal H, Zhang H, Curran MD. 2007. An internally controlled, one-step, real-time RT-PCR assay for norovirus detection and genogrouping. J Clin Virol 39:318-321. http://dx.doi.org/10.1016/j.jcv.2007.05.005.
201. Scipioni A, Bourgot I, Mauroy A, Ziant D, Saegerman C, Daube G, Thiry E. 2008. Detection and quantification of human and bovine noroviruses by a TaqMan RT-PCR assay with a control for inhibition. Mol Cell Probes 22:215-222. http://dx.doi.org/10.1016/j.mcp.2008.02.003.
202. Trujillo AA, McCaustland KA, Zheng DP, Hadley LA, Vaughn G, Adams SM, Ando T, Glass RI, Monroe SS. 2006. Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J Clin Microbiol 44:1405-1412. http://dx.doi.org/10.1128/JCM.44.4.1405-1412.2006.
203. Hymas W, Atkinson A, Stevenson J, Hillyard D. 2007. Use of modified oligonucleotides to compensate for sequence polymorphisms in the realtime detection of norovirus. J Virol Methods 142:10-14. http://dx.doi.org/10.1016/j.jviromet.2006.12.009.
204. Mohamed N, Belak S, Hedlund KO, Blomberg J. 2006. Experience from the development of a diagnostic single tube real-time PCR for human caliciviruses, norovirus genogroups I and II. J Virol Methods 132: 69-76. http://dx.doi.org/10.1016/j.jviromet.2005.09.006.
205. Wolf S, Williamson WM, Hewitt J, Rivera-Aban M, Lin S, Ball A, Scholes P, Greening GE. 2007. Sensitive multiplex real-time reverse transcription-PCR assay for the detection of human and animal noroviruses in clinical and environmental samples. Appl Environ Microbiol 73:5464-5470. http://dx.doi.org/10.1128/AEM.00572-07.
206. Ludert JE, Alcala AC, Liprandi F. 2004. Primer pair p289-p290, designed to detect both noroviruses and sapoviruses by reverse transcription-PCR, also detects rotaviruses by cross-reactivity. J Clin Microbiol 42:835-836. http://dx.doi.org/10.1128/JCM.42.2.835-836.2004.
207. Gunson RN, Carman WF. 2005. Comparison of two real-time PCR methods for diagnosis of norovirus infection in outbreak and community settings. J Clin Microbiol 43:2030-2031. http://dx.doi.org/10.1128/JCM.43.4.2030-2031.2005.
208. Vainio K, Myrmel M. 2006. Molecular epidemiology of norovirus outbreaks in Norway during 2000 to 2005 and comparison of four norovirus real-time reverse transcriptase PCR assays. J Clin Microbiol 44:3695-3702. http://dx.doi.org/10.1128/JCM.00023-06.
209. Jothikumar N, Lowther JA, Henshilwood K, Lees DN, Hill VR, Vinje J. 2005. Rapid and sensitive detection of noroviruses by using TaqManbased one-step reverse transcription-PCR assays and application to naturally contaminated shellfish samples. Appl Environ Microbiol 71:1870-1875. http://dx.doi.org/10.1128/AEM.71.4.1870-1875.2005.
210. Loisy F, Atmar RL, Guillon P, Le Cann P, Pommepuy M, Le Guyader FS. 2005. Real-time RT-PCR for norovirus screening in shellfish. J Virol Methods 123:1-7. http://dx.doi.org/10.1016/j.jviromet.2004.08.023.
211. Vinje J, Hamidjaja RA, Sobsey MD. 2004. Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. J Virol Methods 116:109-117. http://dx.doi.org/10.1016/j.jviromet.2003.11.001.
212. Bon F, Giraudon H, Sancey C, Barranger C, Joannes M, Pothier P, Kohli E. 2004. Development and evaluation of a new commercial test allowing the simultaneous detection of noroviruses and sapoviruses by reverse transcription-PCR and microplate hybridization. J Clin Microbiol 42:2218-2220. http://dx.doi.org/10.1128/JCM.42.5.2218-2220.2004.
213. Kele B, Lengyel G, Deak J. 2011. Comparison of an ELISA and two reverse transcription polymerase chain reaction methods for norovirus detection. Diagn Microbiol Infect Dis 70:475-478. http://dx.doi.org/10.1016/j.diagmicrobio.2011.04.002.
214. Hyun J, Kim HS, Kim HS, Lee KM. 2014. Evaluation of a new real-time reverse transcription polymerase chain reaction assay for detection of norovirus in fecal specimens. Diagn Microbiol Infect Dis 78:40-44. http://dx.doi.org/10.1016/j.diagmicrobio.2013.09.013.
215. Dunbar NL, Bruggink LD, Marshall JA. 2014. Evaluation of the RIDAGENE real-time PCR assay for the detection of GI and GII norovirus. Diagn Microbiol Infect Dis 79:317-321. http://dx.doi.org/10.1016/j.diagmicrobio.2014.03.017.
216. Claas E, Burnham CA, Mazulli T, Templeton K, Topin F. 2013. Performance of the xTAG Gastrointestinal Pathogen Panel (GPP), a multiplex molecular assay for simultaneous detection of bacterial, viral and parasitic causes of infectious gastroenteritis. J Microbiol Biotechnol 23:1041-1045. http://dx.doi.org/10.4014/jmb.1212.12042.
217. Wessels E, Rusman LG, van Bussel MJ, Claas EC. 2014. Added value of multiplex Luminex Gastrointestinal Pathogen Panel (xTAG GPP) testing in the diagnosis of infectious gastroenteritis. Clin Microbiol Infect 20: O182-O187. http://dx.doi.org/10.1111/1469-0691.12364.
218. van Maarseveen NM, Wessels E, de Brouwer CS, Vossen AC, Claas EC. 2010. Diagnosis of viral gastroenteritis by simultaneous detection of adenovirus group F, astrovirus, rotavirus group A, norovirus genogroups I and II, and sapovirus in two internally controlled multiplex real-time PCR assays. J Clin Virol 49:205-210. http://dx.doi.org/10.1016/j.jcv.2010.07.019.
219. Mengelle C, Mansuy JM, Prere MF, Grouteau E, Claudet I, Kamar N, Huynh A, Plat G, Benard M, Marty N, Valentin A, Berry A, Izopet J. 2013. Simultaneous detection of gastrointestinal pathogens with a multiplex Luminex-based molecular assay in stool samples from diarrhoeic patients. Clin Microbiol Infect 19:E458-E465. http://dx.doi.org/10.1111/1469-0691.12255.
220. Navidad JF, Griswold DJ, Gradus MS, Bhattacharyya S. 2013. Evaluation of Luminex xTAG gastrointestinal pathogen analyte-specific reagents for high-throughput, simultaneous detection of bacteria, viruses, and parasites of clinical and public health importance. J Clin Microbiol 51:3018-3024. http://dx.doi.org/10.1128/JCM.00896-13.
221. Kahlau P, Malecki M, Schildgen V, Schulz C, Winterfeld I, Messler S, Mattner F, Schildgen O. 2013. Utility of two novel multiplexing assays for the detection of gastrointestinal pathogens—a first experience. Springerplus 2:106. http://dx.doi.org/10.1186/2193-1801-2-106.
222. Liu J, Gratz J, Amour C, Kibiki G, Becker S, Janaki L, Verweij JJ, Taniuchi M, Sobuz SU, Haque R, Haverstick DM, Houpt ER. 2013. A laboratory-developed TaqMan Array Card for simultaneous detection of 19 enteropathogens. J Clin Microbiol 51:472-480. http://dx.doi.org/10.1128/JCM.02658-12.
223. Liu J, Kibiki G, Maro V, Maro A, Kumburu H, Swai N, Taniuchi M, Gratz J, Toney D, Kang G, Houpt E. 2011. Multiplex reverse transcription PCR Luminex assay for detection and quantitation of viral agents of gastroenteritis. J Clin Virol 50:308-313. http://dx.doi.org/10.1016/j.jcv.2010.12.009.
224. Khare R, Espy MJ, Cebelinski E, Boxrud D, Sloan LM, Cunningham SA, Pritt BS, Patel R, Binnicker MJ. 2014. Multiplex detection of gastrointestinal pathogens: a comparative evaluation of two commercial panels using clinical stool specimens. J Clin Microbiol 52:3667-3673. http://dx.doi.org/10.1128/JCM.01637-14.
225. Greene SR, Moe CL, Jaykus LA, Cronin M, Grosso L, Aarle P. 2003. Evaluation of the NucliSens Basic kit assay for detection of Norwalk virus RNA in stool specimens. J Virol Methods 108:123-131. http://dx.doi.org/10.1016/S0166-0934(02)00286-0.
226. Houde A, Leblanc D, Poitras E, Ward P, Brassard J, Simard C, Trottier YL. 2006. Comparative evaluation of RT-PCR, nucleic acid sequencebased amplification (NASBA) and real-time RT-PCR for detection of noroviruses in faecal material. J Virol Methods 135:163-172. http://dx.doi.org/10.1016/j.jviromet.2006.03.001.
227. Kou X, Wu Q, Zhang J, Fan H. 2006. Rapid detection of noroviruses in fecal samples and shellfish by nucleic acid sequence-based amplification. J Microbiol 44:403-408.
228. Moore C, Clark EM, Gallimore CI, Corden SA, Gray JJ, Westmoreland D. 2004. Evaluation of a broadly reactive nucleic acid sequence based amplification assay for the detection of noroviruses in faecal material. J Clin Virol 29:290-296. http://dx.doi.org/10.1016/S1386-6532(03)00170-7.
229. Patterson SS, Smith MW, Casper ET, Huffman D, Stark L, Fries D, Paul JH. 2006. A nucleic acid sequence-based amplification assay for real-time detection of norovirus genogroup II. J Appl Microbiol 101: 956-963. http://dx.doi.org/10.1111/j.1365-2672.2006.02934.x.
230. Fukuda S, Takao S, Kuwayama M, Shimazu Y, Miyazaki K. 2006. Rapid detection of norovirus from fecal specimens by real-time reverse transcription-loop-mediated isothermal amplification assay. J Clin Microbiol 44:1376-1381. http://dx.doi.org/10.1128/JCM.44.4.1376-1381.2006.
231. Iturriza-Gomara M, Xerry J, Gallimore CI, Dockery C, Gray J. 2008. Evaluation of the Loopamp (loop-mediated isothermal amplification) kit for detecting norovirus RNA in faecal samples. J Clin Virol 42:389-393. http://dx.doi.org/10.1016/j.jcv.2008.02.012.
232. Yoda T, Suzuki Y, Yamazaki K, Sakon N, Kanki M, Aoyama I, Tsukamoto T. 2007. Evaluation and application of reverse transcription loop-mediated isothermal amplification for detection of noroviruses. J Med Virol 79:326-334. http://dx.doi.org/10.1002/jmv.20802.
233. MacCannell T, Umscheid CA, Agarwal RK, Lee I, Kuntz G, Stevenson KB, Healthcare Infection Control Practices Advisory Committee. 2011. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol 32:939-969. http://dx.doi.org/10.1086/662025.
234. Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinje J, Lopman B. 2014. Infection control for norovirus. Clin Microbiol Infect 20:731-740. http://dx.doi.org/10.1111/1469-0691.12674.
235. Kosa KM, Cates SC, Hall AJ, Brophy JE, Frasier A. 2014. Knowledge of norovirus prevention and control among infection preventionists. Am J Infect Control 42:676-678. http://dx.doi.org/10.1016/j.ajic.2014.02.004.
236. Lynn S, Toop J, Hanger C, Millar N. 2004. Norovirus outbreaks in a hospital setting: the role of infection control. N Z Med J 117:U771.
237. Cheng VC, Wong LM, Tai JW, Chan JF, To KK, Li IW, Hung IF, Chan KH, Ho PL, Yuen KY. 2011. Prevention of nosocomial transmission of norovirus by strategic infection control measures. Infect Control Hosp Epidemiol 32:229-237. http://dx.doi.org/10.1086/658330.
238. Albers MK. 2004. An unwanted visitor. Aggressive infection control strategies are needed to shorten the hospital visit of the easily spread norovirus. Can Nurse 100:21-26.
239. Chadwick PR, Beards G, Brown D, Caul EO, Cheesbrough J, Clarke I, Curry A, O’Brien S, Quigley K, Sellwood J, Westmoreland D. 2000. Management of hospital outbreaks of gastro-enteritis due to small roundstructured viruses. J Hosp Infect 45(1):1-10. http://dx.doi.org/10.1053/jhin.2000.0662.
240. Hansen S, Stamm-Balderjahn S, Zuschneid I, Behnke M, Ruden H, Vonberg RP, Gastmeier P. 2007. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 65:348-353. http://dx.doi.org/10.1016/j.jhin.2006.12.018.
241. Lopman BA, Reacher MH, Vipond IB, Hill D, Perry C, Halladay T, Brown DW, Edmunds WJ, Sarangi J. 2004. Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis 10:1827-1834. http://dx.doi.org/10.3201/eid1010.030941.
242. Georgiadou SP, Loukeris D, Smilakou S, Daikos GL, Sipsas NV. 2011. Effective control of an acute gastroenteritis outbreak due to norovirus infection in a hospital ward in Athens, Greece, April 2011. Euro Surveill 16(28):pii_19915. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19915.
243. Russo PL, Spelman DW, Harrington GA, Jenney AW, Gunesekere IC, Wright PJ, Doultree JC, Marshall JA. 1997. Hospital outbreak of Norwalk-like virus. Infect Control Hosp Epidemiol 18:576-579. http://dx.doi.org/10.2307/30141270.
244. Johnston CP, Qiu H, Ticehurst JR, Dickson C, Rosenbaum P, Lawson P, Stokes AB, Lowenstein CJ, Kaminsky M, Cosgrove SE, Green KY, Perl TM. 2007. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis 45:534-540. http://dx.doi.org/10.1086/520666.
245. Fretz R, Schmid D, Jelovcan S, Tschertou R, Krassnitzer E, Schirmer M, Hell M, Allerberger F. 2009. An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wien Klin Wochenschr 121: 137-143. http://dx.doi.org/10.1007/s00508-008-1135-x.
246. Haill CF, Newell P, Ford C, Whitley M, Cox J, Wallis M, Best R, Jenks PJ. 2012. Compartmentalization of wards to cohort symptomatic patients at the beginning and end of norovirus outbreaks. J Hosp Infect 82:30-35. http://dx.doi.org/10.1016/j.jhin.2012.05.015.
247. Illingworth E, Taborn E, Fielding D, Cheesbrough J, Diggle PJ, Orr D. 2011. Is closure of entire wards necessary to control norovirus outbreaks in hospital? Comparing the effectiveness of two infection control strategies. J Hosp Infect 79:32-37. http://dx.doi.org/10.1016/j.jhin.2011.04.024.
248. Cheng FW, Leung TF, Lai RW, Chan PK, Hon EK, Ng PC. 2006. Rapid control of norovirus gastroenteritis outbreak in an acute paediatric ward. Acta Paediatr 95:581-586. http://dx.doi.org/10.1080/08035250500449874.
249. Greig JD, Lee MB. 2012. A review of nosocomial norovirus outbreaks: infection control interventions found effective. Epidemiol Infect 140: 1151-1160. http://dx.doi.org/10.1017/S0950268811002731.
250. McCall J, Smithson R. 2002. Rapid response and strict control measures can contain a hospital outbreak of Norwalk-like virus. Commun Dis Public Health 5:243-246.
251. Cooper E, Blamey S. 2005. A norovirus gastroenteritis epidemic in a long-term-care facility. Infect Control Hosp Epidemiol 26:256-258. http://dx.doi.org/10.1086/502535.
252. Anderson KL. 2009. Norovirus outbreak management in a residentdirected care environment. Geriatr Nurs 30:318-328. http://dx.doi.org/10.1016/j.gerinurse.2009.05.001.
253. Friesema IH, Vennema H, Heijne JC, de Jager CM, Morroy G, van den Kerkhof JH, de Coster EJ, Wolters BA, ter Waarbeek HL, Fanoy EB, Teunis PF, van der Linde R, van Duynhoven YT. 2009. Norovirus outbreaks in nursing homes: the evaluation of infection control measures. Epidemiol Infect 137:1722-1733. http://dx.doi.org/10.1017/S095026880900274X.
254. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America Hand Hygiene Task Force. 2002. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/ APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 23:S3-S40. http://dx.doi.org/10.1086/503164.
255. Park GW, Barclay L, Macinga D, Charbonneau D, Pettigrew CA, Vinje J. 2010. Comparative efficacy of seven hand sanitizers against murine norovirus, feline calicivirus, and GII.4 norovirus. J Food Prot 73:2232-2238.
256. Gehrke C, Steinmann J, Goroncy-Bermes P. 2004. Inactivation of feline calicivirus, a surrogate of norovirus (formerly Norwalk-like viruses), by different types of alcohol in vitro and in vivo. J Hosp Infect 56:49-55. http://dx.doi.org/10.1016/j.jhin.2003.08.019.
257. Kampf G, Grotheer D, Steinmann J. 2005. Efficacy of three ethanolbased hand rubs against feline calicivirus, a surrogate virus for norovirus. J Hosp Infect 60:144-149. http://dx.doi.org/10.1016/j.jhin.2004.12.005.
258. Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. 2010. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol 76:394-399. http://dx.doi.org/10.1128/AEM.01729-09.
259. Lages SL, Ramakrishnan MA, Goyal SM. 2008. In-vivo efficacy of hand sanitisers against feline calicivirus: a surrogate for norovirus. J Hosp Infect 68:159-163. http://dx.doi.org/10.1016/j.jhin.2007.11.018.
260. Weber DJ, Sickbert-Bennett EE, Vinje J, Brown VM, MacFarquhar JK, Engel JP, Rutala WA. 2005. Lessons learned from a norovirus outbreak in a locked pediatric inpatient psychiatric unit. Infect Control Hosp Epidemiol 26:841-843. http://dx.doi.org/10.1086/502504.
261. Cheesbrough JS, Green J, Gallimore CI, Wright PA, Brown DW. 2000. Widespread environmental contamination with Norwalk-like viruses (NLV) detected in a prolonged hotel outbreak of gastroenteritis. EpidemiolInfect 125:93-98. http://dx.doi.org/10.1017/S095026889900432X.
262. Horm KM, Davidson PM, Harte FM, D’Souza DH. 2012. Survival and inactivation of human norovirus surrogates in blueberry juice by highpressure homogenization. Foodborne Pathog Dis 9:974-979. http://dx.doi.org/10.1089/fpd.2012.1171.
263. Horm KM, D’Souza DH. 2011. Survival of human norovirus surrogates in milk, orange, and pomegranate juice, and juice blends at refrigeration (4 degrees C). Food Microbiol 28:1054-1061. http://dx.doi.org/10.1016/j.fm.2011.02.012.
264. Evans MR, Meldrum R, Lane W, Gardner D, Ribeiro CD, Gallimore CI, Westmoreland D. 2002. An outbreak of viral gastroenteritis following environmental contamination at a concert hall. Epidemiol Infect 129:355-360. http://dx.doi.org/10.1017/S0950268802007446.
265. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. 2010. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acineto-bacter species. Am J Infect Control 38:S25-S33. http://dx.doi.org/10.1016/j.ajic.2010.04.196.
266. Barker J, Vipond IB, Bloomfield SF. 2004. Effects of cleaning and disinfection in reducing the spread of norovirus contamination via environmental surfaces. J Hosp Infect 58:42-49. http://dx.doi.org/10.1016/j.jhin.2004.04.021.
267. Jimenez L, Chiang M. 2006. Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: a surrogate for norovirus. Am J Infect Control 34:269-273. http://dx.doi.org/10.1016/j.ajic.2005.11.009.
268. Bolton SL, Kotwal G, Harrison MA, Law SE, Harrison JA, Cannon JL. 2013. Sanitizer efficacy against murine norovirus, a surrogate for human norovirus, on stainless steel surfaces when using three application methods. Appl Environ Microbiol 79:1368-1377. http://dx.doi.org/10.1128/AEM.02843-12.
269. Bok K, Parra GI, Mitra T, Abente E, Shaver CK, Boon D, Engle R, Yu C, Kapikian AZ, Sosnovtsev SV, Purcell RH, Green KY. 2011. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A 108:325-330. http://dx.doi.org/10.1073/pnas.1014577107.
270. Cheetham S, Souza M, Meulia T, Grimes S, Han MG, Saif LJ. 2006. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol 80:10372-10381. http://dx.doi.org/10.1128/JVI.00809-06.
271. Souza M, Azevedo MS, Jung K, Cheetham S, Saif LJ. 2008. Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J Virol 82:1777-1786. http://dx.doi.org/10.1128/JVI.01347-07.
272. Chang KO, Sosnovtsev SV, Belliot G, King AD, Green KY. 2006. Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology 353:463-473. http://dx.doi.org/10.1016/j.virol.2006.06.006.
273. Katayama K, Murakami K, Sharp TM, Guix S, Oka T, Takai-Todaka R, Nakanishi A, Crawford SE, Atmar RL, Estes MK. 2014. Plasmid-based humannorovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A 111: E4043-E4052. http://dx.doi.org/10.1073/pnas.1415096111.
274. Taube S, Kolawole AO, Hohne M, Wilkinson JE, Handley SA, Perry JW, Thackray LB, Akkina R, Wobus CE. 2013. A mouse model for human norovirus. mBio 4(4):e00450-13. http://dx.doi.org/10.1128/mBio.00450-13.
275. Taube S, Rubin JR, Katpally U, Smith TJ, Kendall A, Stuckey JA, Wobus CE. 2010. High-resolution X-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain. J Virol 84:5695-5705. http://dx.doi.org/10.1128/JVI.00316-10.
276. Ohsugi T, Matsuura K, Kawabe S, Nakamura N, Kumar JM, Wakamiya M, Morikawa S, Urano T. 2013. Natural infection of murine norovirus in conventional and specific pathogen-free laboratory mice. Front Microbiol 4:12. http://dx.doi.org/10.3389/fmicb.2013.00012.
277. Pritchett-Corning KR, Cosentino J, Clifford CB. 2009. Contemporary prevalence of infectious agents in laboratory mice and rats. Lab Anim 43:165-173. http://dx.doi.org/10.1258/la.2008.008009.
278. Thackray LB, Duan E, Lazear HM, Kambal A, Schreiber RD, Diamond MS, Virgin HW. 2012. Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J Virol 86:13515-13523. http://dx.doi.org/10.1128/JVI.01824-12.
279. Changotra H, Jia Y, Moore TN, Liu G, Kahan SM, Sosnovtsev SV, Karst SM. 2009. Type I and type II interferons inhibit the translation of murine norovirus proteins. J Virol 83:5683-5692. http://dx.doi.org/10.1128/JVI.00231-09.
280. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol 81:3251-3263. http://dx.doi.org/10.1128/JVI.02096-06.
281. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW, IV. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299:1575-1578. http://dx.doi.org/10.1126/science.1077905.
282. Hwang S, Maloney NS, Bruinsma MW, Goel G, Duan E, Zhang L, Shrestha B, Diamond MS, Dani A, Sosnovtsev SV, Green KY, Lopez-Otin C, Xavier RJ, Thackray LB, Virgin HW. 2012. Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 11:397-409. http://dx.doi.org/10.1016/j.chom.2012.03.002.
283. Elftman MD, Gonzalez-Hernandez MB, Kamada N, Perkins C, Henderson KS, Nunez G, Wobus CE. 2013. Multiple effects of dendritic cell depletion on murine norovirus infection. J Gen Virol 94:1761-1768. http://dx.doi.org/10.1099/vir.0.052134-0.
284. Fang H, Tan M, Xia M, Wang L, Jiang X. 2013. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 8:e63269. http://dx.doi.org/10.1371/journal.pone.0063269.
285. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog 4:e1000108. http://dx.doi.org/10.1371/journal.ppat.1000108.
286. Wobus CE, Thackray LB, Virgin HW, IV. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol 80: 5104-5112. http://dx.doi.org/10.1128/JVI.02346-05.
287. Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. 2008. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog 4:e1000236. http://dx.doi.org/10.1371/journal.ppat.1000236.
288. McFadden N, Bailey D, Carrara G, Benson A, Chaudhry Y, Shortland A, Heeney J, Yarovinsky F, Simmonds P, Macdonald A, Goodfellow I. 2011. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PloS Pathog 7:e1002413. http://dx.doi.org/10.1371/journal.ppat.1002413.
289. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent.NEngl J Med 297:86-89. http://dx.doi.org/10.1056/NEJM197707142970204.
290. Marionneau S, Ruvoen N, Le Moullac-Vaidye B, Clement M, Cailleau-Thomas A, Ruiz-Palacois G, Huang P, Jiang X, Le Pendu J. 2002. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122: 1967-1977. http://dx.doi.org/10.1053/gast.2002.33661.
291. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, Clement M, Le Pendu J. 2001. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83:565-573. http://dx.doi.org/10.1016/S0300-9084(01)01321-9.
292. Vicentini F, Denadai W, Gomes YM, Rose TL, Ferreira MS, Le Moullac-Vaidye B, Le Pendu J, Leite JP, Miagostovich MP, Spano LC. 2013. Molecular characterization of noroviruses and HBGA from infected Quilombola children in Espirito Santo State, Brazil. PLoS One 8:e69348. http://dx.doi.org/10.1371/journal.pone.0069348.
293. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. 1995. Sequence and expression of a candidate for the human secretor blood group alpha(1, 2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640-4649. http://dx.doi.org/10.1074/jbc.270.9.4640.
294. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548-553. http://dx.doi.org/10.1038/nm860.
295. Hutson AM, Atmar RL, Marcus DM, Estes MK. 2003. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol 77:405-415. http://dx.doi.org/10.1128/JVI.77.1.405-415.2003.
296. Hutson AM, Atmar RL, Estes MK. 2004. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol 12:279-287. http://dx.doi.org/10.1016/j.tim.2004.04.005.
297. Rydell GE, Kindberg E, Larson G, Svensson L. 2011. Susceptibility to winter vomiting disease: a sweet matter. RevMedVirol 21:370-382. http://dx.doi.org/10.1002/rmv.704.
298. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343. http://dx.doi.org/10.1128/JVI.76.23.12335-12343.2002.
299. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, Roche N, Vikstrom S, Sjostrom R, Linden S, Backstrom A, Lundberg C, Arnqvist A, Mahdavi J, Nilsson UJ, Velapatino B, Gilman RH, Gerhard M, Alarcon T, Lopez-Brea M, Nakazawa T, Fox JG, Correa P, Dominguez-Bello MG, Perez-Perez GI, Blaser MJ, Normark S, Carlstedt I, Oscarson S, Teneberg S, Berg DE, Boren T. 2004. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305:519-522. http://dx.doi.org/10.1126/science.1098801.
300. Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. 1996. Human blood groups: incidental receptors for viruses and bacteria. Transfusion 36: 362-374. http://dx.doi.org/10.1046/j.1537-2995.1996.36496226154.x.
301. Huang P, Farkas T, Zhong W, Tan M, Thornton S, Morrow AL, Jiang X. 2005. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79:6714-6722. http://dx.doi.org/10.1128/JVI.79.11.6714-6722.2005.
302. Frenck R, Bernstein DI, Xia M, Huang P, Zhong W, Parker S, Dickey M, McNeal M, Jiang X. 2012. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis 206: 1386-1393. http://dx.doi.org/10.1093/infdis/jis514.
303. Hutson AM, Atmar RL, Graham DY, Estes MK. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185:1335-1337. http://dx.doi.org/10.1086/339883.
304. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoen-Clouet N. 2005. Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis 192:1071-1077. http://dx.doi.org/10.1086/432546.
305. Shirato H. 2012. Norovirus recognition sites on histo-blood group antigens. Front Microbiol 3:177. http://dx.doi.org/10.3389/fmicb.2012.00177.
306. Shirato H. 2011. Norovirus and histo-blood group antigens. Jpn J Infect Dis 64:95-103.
307. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 79:2900-2909. http://dx.doi.org/10.1128/JVI.79.5.2900-2909.2005.
308. Carlsson B, Kindberg E, Buesa J, Rydell GE, Lidon MF, Montava R, Abu Mallouh R, Grahn A, Rodriguez-Diaz J, Bellido J, Arnedo A, Larson G, Svensson L. 2009. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection. PLoS One 4:e5593. http://dx.doi.org/10.1371/journal.pone.0005593.
309. Jin M, He Y, Li H, Huang P, Zhong W, Yang H, Zhang H, Tan M, Duan ZJ. 2013. Two gastroenteritis outbreaks caused by GII noroviruses: host susceptibility and HBGA phenotypes. PLoS One 8:e58605. http://dx.doi.org/10.1371/journal.pone.0058605.
310. Nordgren J, Kindberg E, Lindgren PE, Matussek A, Svensson L. 2010. Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg Infect Dis 16:81-87. http://dx.doi.org/10.3201/eid1601.090633.
311. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP. 2005. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191:749-754. http://dx.doi.org/10.1086/427779.
312. Murakami K, Kurihara C, Oka T, Shimoike T, Fujii Y, Takai-Todaka R, Park Y, Wakita T, Matsuda T, Hokari R, Miura S, Katayama K. 2013. Norovirus binding to intestinal epithelial cells is independent of histo-blood group antigens. PLoS One 8:e66534. http://dx.doi.org/10.1371/journal.pone.0066534.
313. Harrington PR, Vinje J, Moe CL, Baric RS. 2004. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J Virol 78:3035-3045. http://dx.doi.org/10.1128/JVI.78.6.3035-3045.2004.
314. Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo DC, Hayes P, Okhuysen PC. 2007. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis 44:945-952. http://dx.doi.org/10.1086/512199.
315. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB. 1990. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 161:18-21. http://dx.doi.org/10.1093/infdis/161.1.18.
316. Simmons K, Gambhir M, Leon J, Lopman B. 2013. Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis 19:1260-1267. http://dx.doi.org/10.3201/eid1908.130472.
317. Teunis PF, Moe CL, Liu P, Miller SE, Lindesmith L, Baric RS, Le Pendu J, Calderon RL. 2008. Norwalk virus: how infectious is it? J Med Virol 80:1468-1476. http://dx.doi.org/10.1002/jmv.21237.
318. Atmar RL, Estes MK. 2012. Norovirus vaccine development: next steps. Expert Rev Vaccines 11:1023-1025. http://dx.doi.org/10.1586/erv.12.78.
319. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Ramani S, Hill H, Ferreira J, Graham DY. 2014. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis 209:1016-1022. http://dx.doi.org/10.1093/infdis/jit620.
320. Chan MC, Sung JJ, Lam RK, Chan PK, Lee NL, Lai RW, Leung WK. 2006. Fecal viral load and norovirus-associated gastroenteritis. Emerg Infect Dis 12:1278-1280. http://dx.doi.org/10.3201/eid1208.060081.
321. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM. 1974. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis 129:709-714. http://dx.doi.org/10.1093/infdis/129.6.709.
322. Saito M, Goel-Apaza S, Espetia S, Velasquez D, Cabrera L, Loli S, Crabtree JE, Black RE, Kosek M, Checkley W, Zimic M, Bern C, Cama V, Gilman RH, Norovirus Working Group in Peru. 2014. Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis 58:483-491. http://dx.doi.org/10.1093/cid/cit763.
323. Koo HL, Ajami N, Atmar RL, DuPont HL. 2010. Noroviruses: the leading cause of gastroenteritis worldwide. Discov Med 10:61-70.
324. Rockx B, Baric RS, de Grijs I, Duizer E, Koopmans MP. 2005. Characterization of the homo-and heterotypic immune responses after natural norovirus infection. J Med Virol 77:439-446. http://dx.doi.org/10.1002/jmv.20473.
325. Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, Graham DY, Atmar RL. 2010. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 202:1212-1218. http://dx.doi.org/10.1086/656364.
326. Ryder RW, Singh N, Reeves WC, Kapikian AZ, Greenberg HB, Sack RB. 1985. Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J Infect Dis 151:99-105. http://dx.doi.org/10.1093/infdis/151.1.99.
327. Kuritsky JN, Osterholm MT, Korlath JA, White KE, Kaplan JE. 1985. A statewide assessment of the role of Norwalk virus in outbreaks of foodborne gastroenteritis. J Infect Dis 151:568. http://dx.doi.org/10.1093/infdis/151.3.568.
328. Lindesmith LC, Donaldson E, Leon J, Moe CL, Frelinger JA, Johnston RE, Weber DJ, Baric RS. 2010. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol 84:1800-1815. http://dx.doi.org/10.1128/JVI.02179-09.
329. Ajami NJ, Barry MA, Carrillo B, Muhaxhiri Z, Neill FH, Prasad BV, Opekun AR, Gilger MA, Graham DY, Atmar RL, Estes MK. 2012. Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol 19: 1980-1983. http://dx.doi.org/10.1128/CVI.00411-12.
330. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290. http://dx.doi.org/10.1126/science.286.5438.287.
331. Lochridge VP, Hardy ME. 2007. A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization. J Virol 81:12316-12322. http://dx.doi.org/10.1128/JVI.01254-07.
332. Chen Y, Tan M, Xia M, Hao N, Zhang XC, Huang P, Jiang X, Li X, Rao Z. 2011. Crystallography of a Lewis-binding norovirus, elucidation of strainspecificity to the polymorphic human histo-blood group antigens. PloS Pathog 7:e1002152. http://dx.doi.org/10.1371/journal.ppat.1002152.
333. Chen L, Wu D, Ji L, Wu X, Xu D, Cao Z, Han J. 2013. Bioinformatics analysis of the epitope regions for norovirus capsid protein. BMC Bioinformatics 14(Suppl 4):S5. http://dx.doi.org/10.1186/1471-2105-14-S4-S5.
334. Lindesmith LC, Donaldson EF, Baric RS. 2011. Norovirus GII.4 strain antigenic variation. J Virol 85:231-242. http://dx.doi.org/10.1128/JVI.01364-10.
335. Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog 6:e1000831. http://dx.doi.org/10.1371/journal.ppat.1000831.
336. Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, Prasad BV. 2011. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol 85:8635-8645. http://dx.doi.org/10.1128/JVI.00848-11.
337. Allen DJ, Gray JJ, Gallimore CI, Xerry J, Iturriza-Gomara M. 2008. Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One 3:e1485. http://dx.doi.org/10.1371/journal.pone.0001485.
338. de Rougemont A, Ruvoen-Clouet N, Simon B, Estienney M, Elie-Caille C, Aho S, Pothier P, Le Pendu J, Boireau W, Belliot G. 2011. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J Virol 85:4057-4070. http://dx.doi.org/10.1128/JVI.02077-10.
339. Iritani N, Kaida A, Kubo H, Abe N, Murakami T, Vennema H, Koopmans M, Takeda N, Ogura H, Seto Y. 2008. Epidemic of genotype GII.2 noroviruses during spring 2004 in Osaka City, Japan. J Clin Microbiol 46:2406-2409. http://dx.doi.org/10.1128/JCM.01993-07.
340. Iritani N, Vennema H, Siebenga JJ, Siezen RJ, Renckens B, Seto Y, Kaida A, Koopmans M. 2008. Genetic analysis of the capsid gene of genotype GII.2 noroviruses. J Virol 82:7336-7345. http://dx.doi.org/10.1128/JVI.02371-07.
341. Ramani S, Atmar RL, Estes MK. 2014. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol 30:25-33. http://dx.doi.org/10.1097/MOG.0000000000000022.
342. Debbink K, Donaldson EF, Lindesmith LC, Baric RS. 2012. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol 86:1214-1226. http://dx.doi.org/10.1128/JVI.06189-11.
343. Debbink K, Lindesmith LC, Donaldson EF, Baric RS. 2012. Norovirus immunity and the great escape. PLoS Pathog 8:e1002921. http://dx.doi.org/10.1371/journal.ppat.1002921.
344. Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinje J, Baric RS. 2013. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 208:1877-1887. http://dx.doi.org/10.1093/infdis/jit370.
345. Chan-It W, Thongprachum A, Okitsu S, Mizuguchi M, Ushijima H. 2014. Genetic analysis and homology modeling of capsid protein of norovirus GII.14. J Med Virol 86:329-334. http://dx.doi.org/10.1002/jmv.23720.
346. Hoffmann D, Hutzenthaler M, Seebach J, Panning M, Umgelter A, Menzel H, Protzer U, Metzler D. 2012. Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients. Infect Genet Evol 12:461-466. http://dx.doi.org/10.1016/j.meegid.2012.01.020.
347. Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. 2012. The potential economic value of a human norovirus vaccine for the United States. Vaccine 30:7097-7104. http://dx.doi.org/10.1016/j.vaccine.2012.09.040.
348. Richardson C, Bargatze RF, Goodwin R, Mendelman PM. 2013. Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis. Expert Rev Vaccines 12:155-167. http://dx.doi.org/10.1586/erv.12.145.
349. Tan M, Jiang X. 2012. The formation of P particle increased immunogenicity of norovirus P protein. Immunology 136:28-29. http://dx.doi.org/10.1111/j.1365-2567.2012.03555.x.
350. Tamminen K, Huhti L, Koho T, Lappalainen S, Hytonen VP, Vesikari T, Blazevic V. 2012. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology 135:89-99. http://dx.doi.org/10.1111/j.1365-2567.2011.03516.x.
351. Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. 2010. Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149-1176. http://dx.doi.org/10.1586/erv.10.115.
352. Herbst-Kralovetz M, Mason HS, Chen Q. 2010. Norwalk virus-like particles as vaccines. Expert Rev Vaccines 9:299-307. http://dx.doi.org/10.1586/erv.09.163.
353. Ball JM, Graham DY, Opekun AR, Gilger MA, Guerrero RA, Estes MK. 1999. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 117:40-48. http://dx.doi.org/10.1016/S0016-5085(99)70548-2.
354. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Estes MK. 2003. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 108:241-247. http://dx.doi.org/10.1016/S1521-6616(03)00120-7.
355. El-Kamary SS, Pasetti MF, Mendelman PM, Frey SE, Bernstein DI, Treanor JJ, Ferreira J, Chen WH, Sublett R, Richardson C, Bargatze RF, Sztein MB, Tacket CO. 2010. Adjuvanted intranasal Norwalk viruslike particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 202:1649-1658. http://dx.doi.org/10.1086/657087.
356. Ramirez K, Wahid R, Richardson C, Bargatze RF, El-Kamary SS, Sztein MB, Pasetti MF. 2012. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol 144:98-108. http://dx.doi.org/10.1016/j.clim.2012.05.006.
357. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, Mendelman PM. 2011. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 365:2178-2187. http://dx.doi.org/10.1056/NEJMoa1101245.
358. Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinje J, Gregoricus N, Frenck RW, Jr, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM. 9 September 2014. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. http://dx.doi.org/10.1093/infdis/jiu497.
359. Parra GI, Azure J, Fischer R, Bok K, Sandoval-Jaime C, Sosnovtsev SV, Sander P, Green KY. 2013. Identification of a broadly cross-reactive epitope in the inner shell of the norovirus capsid. PLoS One 8:e67592. http://dx.doi.org/10.1371/journal.pone.0067592.
360. Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T. 2011. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine 29:8126-8133. http://dx.doi.org/10.1016/j.vaccine.2011.08.026.
361. Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. 2013. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 8:e70409. http://dx.doi.org/10.1371/journal.pone.0070409.
362. Wang L, Cao D, Wei C, Meng XJ, Jiang X, Tan M. 2014. A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine 32:445-452. http://dx.doi.org/10.1016/j.vaccine.2013.11.064.
363. Richards AF, Lopman B, Gunn A, Curry A, Ellis D, Cotterill H, Ratcliffe S, Jenkins M, Appleton H, Gallimore CI, Gray JJ, Brown DW. 2003. Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J Clin Virol 26:109-115. http://dx.doi.org/10.1016/S1386-6532(02)00267-6.
364. Green SM, Lambden PR, Deng Y, Lowes JA, Lineham S, Bushell J, Rogers J, Caul EO, Ashley CR, Clarke IN. 1995. Polymerase chain reaction detection of small round-structured viruses from two related hospital outbreaks of gastroenteritis using inosine-containing primers. J Med Virol 45:197-202. http://dx.doi.org/10.1002/jmv.1890450215.
365. Burton-MacLeod JA, Kane EM, Beard RS, Hadley LA, Glass RI, Ando T. 2004. Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples. J Clin Microbiol 42:2587-2595. http://dx.doi.org/10.1128/JCM.42.6.2587-2595.2004.
366. Fleischer J, Wagner Wiening C, Kimmig P. 2000. Surveillance of group illnesses with Norwalk-like viruses (NLV) in Baden-Wurttemberg. Isolation and detection of Norwalk-like viral RNA from fecal samples with RT-PCR. Gesundheitswesen 62:604-608. (In German.) http://dx.doi.org/10.1055/s-2000-13042.
367. Dimitriadis A, Marshall JA. 2005. Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens. Eur J Clin Microbiol Infect Dis 24:615-618. http://dx.doi.org/10.1007/s10096-005-0012-z.
368. Yuen LK, Catton MG, Cox BJ, Wright PJ, Marshall JA. 2001. Heminested multiplex reverse transcription-PCR for detection and differentiation of Norwalk-like virus genogroups 1 and 2 in fecal samples. J Clin Microbiol 39:2690-2694. http://dx.doi.org/10.1128/JCM.39.7.2690-2694.2001.
369. Dimitriadis A, Bruggink LD, Marshall JA. 2006. Evaluation of the Dako IDEIA norovirus EIA assay for detection of norovirus using faecal specimens from Australian gastroenteritis outbreaks. Pathology 38:157-165. http://dx.doi.org/10.1080/00313020600559645.
370. de Bruin E, Duizer E, Vennema H, Koopmans MP. 2006. Diagnosis of norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods 137:259-264. http://dx.doi.org/10.1016/j.jviromet.2006.06.024.
371. Gonzalez GG, Liprandi F, Ludert JE. 2006. Evaluation of a commercial enzyme immunoassay for the detection of norovirus antigen in fecal samples from children with sporadic acute gastroenteritis. J Virol Methods 136:289-291. http://dx.doi.org/10.1016/j.jviromet.2006.05.024.
372. Castriciano S, Luinstra K, Petrich A, Smieja M, Lee C, Jang D, Portillo E, Chernesky M. 2007. Comparison of the RIDASCREEN norovirus enzyme immunoassay to IDEIA NLV GI/GII by testing stools also as-sayed by RT-PCR and electron microscopy. J Virol Methods 141:216-219. http://dx.doi.org/10.1016/j.jviromet.2006.12.001.
373. Wilhelmi de Cal I, Revilla A, del Alamo JM, Roman E, Moreno S, Sanchez-Fauquier A. 2007. Evaluation of two commercial enzyme immunoassays for the detection of norovirus in faecal samples from hospitalized children with sporadic acute gastroenteritis. Clin Microbiol Infect 13:341-343. http://dx.doi.org/10.1111/j.1469-0691.2006.01594.x.
374. Jiang X, Huang PW, Zhong WM, Farkas T, Cubitt DW, Matson DO. 1999. Design and evaluation of a primer pair that detects both Norwalkand Sapporo-like caliciviruses by RT-PCR. J Virol Methods 83:145-154. http://dx.doi.org/10.1016/S0166-0934(99)00114-7.
375. Kirby A, Gurgel RQ, Dove W, Vieira SC, Cunliffe NA, Cuevas LE. 2010. An evaluation of the RIDASCREEN and IDEIA enzyme immunoassays and the RIDAQUICK immunochromatographic test for the detection of norovirus in faecal specimens. J Clin Virol 49:254-257. http://dx.doi.org/10.1016/j.jcv.2010.08.004.
376. Morillo SG, Luchs A, Cilli A, Ribeiro CD, Calux SJ, Carmona RCC, Timenetsky MCST. 2011. Norovirus 3rd generation kit: an improvement for rapid diagnosis of sporadic gastroenteritis cases and valuable for outbreak detection. J Virol Methods 173:13-16. http://dx.doi.org/10.1016/j.jviromet.2010.12.017.
377. Fankhauser RL, Monroe SS, Noel JS, Humphrey CD, Bresee JS, Parashar UD, Ando T, Glass RI. 2002. Epidemiologic and molecular trends of “Norwalk-like viruses” associated with outbreaks of gastroenteritis in the United States. J Infect Dis 186:1-7. http://dx.doi.org/10.1086/341085.
378. Siqueira JAM, Linhares AC, Oliveira DS, Soares LS, Lucena MS, Wanzeller AL, Mascarenhas JD, Gabbay YB. 2011. Evaluation of thirdgeneration RIDASCREEN enzyme immunoassay for the detection of norovirus antigens in stool samples of hospitalized children in Belem, Para, Brazil. Diagn Microbiol Infect Dis 71:391-395. http://dx.doi.org/10.1016/j.diagmicrobio.2011.08.023.
379. Geginat G, Kaiser D, Schrempf S. 2012. Evaluation of third-generation ELISA and a rapid immunochromatographic assay for the detection of norovirus infection in fecal samples from inpatients of a German tertiary care hospital. Eur J Clin Microbiol Infect Dis 31:733-737. http://dx.doi.org/10.1007/s10096-011-1366-z.
380. Rovida F, Campanini G, Sarasini A, Adzasehoun KM, Piralla A, Baldanti F. 2013. Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. Diagn Microbiol Infect Dis 75:110-111. http://dx.doi.org/10.1016/j.diagmicrobio.2012.09.016.
381. Mattison K, Grudeski E, Auk B, Charest H, Drews SJ, Fritzinger A, Gregoricus N, Hayward S, Houde A, Lee BE, Pang XL, Wong J, Booth TF, Vinje J. 2009. Multicenter comparison of two norovirus ORF2-based genotyping protocols. J Clin Microbiol 47:3927-3932. http://dx.doi.org/10.1128/JCM.00497-09.
382. Takanashi S, Okame M, Shiota T, Takagi M, Yagyu F, Tung PG, Nishimura S, Katsumata N, Igarashi T, Okitsu S, Ushijima H. 2008. Development of a rapid immunochromatographic test for noroviruses genogroups I and II. J Virol Methods 148:1-8. http://dx.doi.org/10.1016/j.jviromet.2007.10.010.
383. Yan H, Yagyu F, Okitsu S, Nishio O, Ushijima H. 2003. Detection of norovirus (GI, GII), sapovirus and astrovirus in fecal samples using reverse transcription single-round multiplex PCR. J Virol Methods 114: 37-44. http://dx.doi.org/10.1016/j.jviromet.2003.08.009.
384. Derrington P, Schreiber F, Day S, Curtis C, Lyon M. 2009. Norovirus Ridaquick: a new test for rapid diagnosis of norovirus. Pathology 41:687-688. http://dx.doi.org/10.3109/00313020903305886.
385. Bruins MJ, Wolfhagen MJ, Schirm J, Ruijs GJ. 2010. Evaluation of a rapid immunochromatographic test for the detection of norovirus in stool samples. Eur J Clin Microbiol Infect Dis 29:741-743. http://dx.doi.org/10.1007/s10096-010-0911-5.
386. Bruggink LD, Witlox KJ, Sameer R, Catton MG, Marshall JA. 2011. Evaluation of the RIDAQUICK immunochromatographic norovirus detection assay using specimens from Australian gastroenteritis incidents. J Virol Methods 173:121-126. http://dx.doi.org/10.1016/j.jviromet.2011.01.017.
387. Battaglioli G, Nazarian EJ, Lamson D, Musser KA, St George K. 2012. Evaluation of the RIDAQuick norovirus immunochromatographic test kit. J Clin Virol 53:262-264. http://dx.doi.org/10.1016/j.jcv.2011.12.007.
388. Kim HS, Hyun J, Kim JS, Song W, Kang HJ, Lee KM. 2012. Evaluation of the SD Bioline norovirus rapid immunochromatography test using fecal specimens from Korean gastroenteritis patients. J Virol Methods 186:94-98. http://dx.doi.org/10.1016/j.jviromet.2012.08.014.
389. Park KS, Baek KA, Kim DU, Kwon KS, Bing SH, Park JS, Nam HS, Lee SH, Choi YJ. 2012. Evaluation of a new immunochromatographic assay kit for the rapid detection of norovirus in fecal specimens. Ann Lab Med 32:79-81. http://dx.doi.org/10.3343/alm.2012.32.1.79.
390. Pombubpa K, Kittigul L. 2012. Assessment of a rapid immunochromatographic test for the diagnosis of norovirus gastroenteritis. Eur J Clin Microbiol Infect Dis 31:2379-2383. http://dx.doi.org/10.1007/s10096-012-1579-9.
391. Ambert-Balay K, Pothier P. 2013. Evaluation of 4 immunochromatographic tests for rapid detection of norovirus in faecal samples. J Clin Virol 56:194-198. http://dx.doi.org/10.1016/j.jcv.2012.11.001.
392. Sdiri-Loulizi K, Ambert-Balay K, Gharbi-Khelifi H, Sakly N, Hassine M, Chouchane S, Guediche MN, Pothier P, Aouni M. 2009. Molecular epidemiology of norovirus gastroenteritis investigated using samples collected from children in Tunisia during a four-year period: detection of the norovirus variant GGII.4 Hunter as early as January 2003. J Clin Microbiol 47:421-429. http://dx.doi.org/10.1128/JCM.01852-08.
393. Kittigul L, Pombubpa K, Taweekate Y, Diraphat P, Sujirarat D, Khamrin P, Ushijima H. 2010. Norovirus GII-4 2006b variant circulating in patients with acute gastroenteritis in Thailand during a 2006-2007 study. J Med Virol 82:854-860. http://dx.doi.org/10.1002/jmv.21746.
394. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, Gonzalez-Hernandez MB, Iovine NM, Wobus CE, Vinjé J, Tibbetts SA, Wallet SM, Karst SM. 2014. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346:755-759. http://dx.doi.org/10.1126/science.1257147.